A. Lynn

Generation of retroviral packaging and producer cell lines for large-scale vector production and clinical application: improved safety and high titer.

S. Chang, P. Sheridan, T. Dubensky, 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

Antigen presentation in retroviral vector-mediated gene transfer in vivo.

S. Chada, V. Lee, C. Surh, 1997, Proceedings of the National Academy of Sciences of the United States of America.

Cytotoxic T lymphocyte and antibody responses generated in rhesus monkeys immunized with retroviral vector-transduced fibroblasts expressing human immunodeficiency virus type-1 IIIB ENV/REV proteins.

B. Howard, M. Burrascano, W. Lee, 1994, Human gene therapy.

Optimization of Lipid Nanoparticles for Intramuscular Administration of mRNA Vaccines

Kimberly J. Hassett, M. Moore, C. Mihai, 2019, Molecular therapy. Nucleic acids.

A Novel Amino Lipid Series for mRNA Delivery: Improved Endosomal Escape and Sustained Pharmacology and Safety in Non-human Primates.

Örn Almarsson, C. Mihai, Joe J. Senn, 2018, Molecular therapy : the journal of the American Society of Gene Therapy.

Systemic mRNA Therapy for the Treatment of Fabry Disease: Preclinical Studies in Wild-Type Mice, Fabry Mouse Model, and Wild-Type Non-human Primates.

C. Lukacs, L. Guey, K. Burke, 2019, American journal of human genetics.

Safety Evaluation of Lipid Nanoparticle–Formulated Modified mRNA in the Sprague-Dawley Rat and Cynomolgus Monkey

J. Bolen, Joe J. Senn, A. Bulychev, 2018, Veterinary pathology.